Literature DB >> 32960462

CKS1B promotes cell proliferation and invasion by activating STAT3/PD-L1 and phosphorylation of Akt signaling in papillary thyroid carcinoma.

Hui Wang1, Zhengdong Zhang1, Zhe Yan1, Shihong Ma1.   

Abstract

OBJECTIVE: To investigate role of GKS1B and its relationship between STAT3/PD-L1 and p-Akt in papillary thyroid carcinoma (PTC).
METHODS: Expression of GKS1B and PD-L1 was determined in PTC cell lines. GKS1B was overexpressed or knocked down by transfection with overexpression plasmids or si-CKS1B. STAT3 inhibitor WP1066 was used to suppress STAT3, and PD-L1 inhibitor Pembrolizumab was used to block PD-L1. Cell viability and invasion were evaluated by MTT and transwell assay, respectively. The expression of STAT3, p-STAT3, Akt, and p-Akt was measured using Western blotting.
RESULTS: Both protein levels and mRNA levels of CKS1B and PD-L1 were remarkably up-regulated in PTC cell lines. Knockdown of CKS1B significantly inhibited cell viability and invasion of PTC cells and suppressed STAT3/PD-L1 signaling and Akt phosphorylation, while overexpression of CKS1B led to opposite results. Inhibition of STAT3 or PD-L1 reversed the effects of overexpressed CKS1B on PTC cells.
CONCLUSION: The overexpression of CSK1B could promote cell viability and invasion of PTC cells through activation of STAT3/PD-L1 signaling and Akt phosphorylation.
© 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals LLC.

Entities:  

Keywords:  Akt; CKS1B; STAT3/PD-L1; papillary thyroid carcinoma

Year:  2020        PMID: 32960462      PMCID: PMC7843292          DOI: 10.1002/jcla.23565

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  23 in total

1.  Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer.

Authors:  Kristin J Lastwika; Willie Wilson; Qing Kay Li; Jeffrey Norris; Haiying Xu; Sharon R Ghazarian; Hiroshi Kitagawa; Shigeru Kawabata; Janis M Taube; Sheng Yao; Linda N Liu; Joell J Gills; Phillip A Dennis
Journal:  Cancer Res       Date:  2015-12-04       Impact factor: 12.701

2.  Genetic landscape of papillary thyroid carcinoma in the Chinese population.

Authors:  Jialong Liang; Wanshi Cai; Dongdong Feng; Huajing Teng; Fengbiao Mao; Yi Jiang; Shanshan Hu; Xianfeng Li; Yujie Zhang; Baoguo Liu; Zhong Sheng Sun
Journal:  J Pathol       Date:  2017-12-28       Impact factor: 7.996

Review 3.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

4.  CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.

Authors:  Gemma Martín-Ezquerra; Rocío Salgado; Agustí Toll; Teresa Baró; Sergi Mojal; Mireia Yébenes; Ma Pilar Garcia-Muret; Francesc Solé; Francesc Alameda Quitllet; Blanca Espinet; Ramon M Pujol
Journal:  Histol Histopathol       Date:  2011-01       Impact factor: 2.303

5.  Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.

Authors:  Daniel Lubin; Ezra Baraban; Amanda Lisby; Sahar Jalali-Farahani; Paul Zhang; Virginia Livolsi
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

6.  Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.

Authors:  Lei Shi; Siqing Wang; Maurizio Zangari; Hongwei Xu; Thai M Cao; Chunjiao Xu; Yong Wu; Fang Xiao; Yinghong Liu; Ye Yang; Mohamed Salama; Guiyuan Li; Guido Tricot; Fenghuang Zhan
Journal:  Oncotarget       Date:  2010-05

7.  Insights into the Management of Papillary Microcarcinoma of the Thyroid.

Authors:  Akira Miyauchi; Yasuhiro Ito; Hitomi Oda
Journal:  Thyroid       Date:  2017-09-22       Impact factor: 6.568

8.  miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer.

Authors:  Jie Wang; Xing-Jun Guo; You-Ming Ding; Jian-Xin Jiang
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

9.  Elevated levels of soluble PD-L1 are associated with reduced recurrence in papillary thyroid cancer.

Authors:  Marra Jai Aghajani; Tara Laurine Roberts; Tao Yang; Charles Eugenio McCafferty; Nicole J Caixeiro; Paul DeSouza; Navin Niles
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

10.  AKT-STAT3 Pathway as a Downstream Target of EGFR Signaling to Regulate PD-L1 Expression on NSCLC cells.

Authors:  Sherif Abdelhamed; Keisuke Ogura; Satoru Yokoyama; Ikuo Saiki; Yoshihiro Hayakawa
Journal:  J Cancer       Date:  2016-07-18       Impact factor: 4.207

View more
  2 in total

1.  Regulation of microRNA miR-197-3p/CDC28 protein kinase regulatory subunit 1B (CKS1B) axis by Circular RNA hsa_circ_0000285 promotes glioma progression.

Authors:  Tao Deng; Yang Liu; Yanlong Yang; Leyong Yuan; Fangfang Liu; Xiaobo Wang; Qiuying Zhang; Mingshui Xie
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

2.  CKS1B promotes cell proliferation and invasion by activating STAT3/PD-L1 and phosphorylation of Akt signaling in papillary thyroid carcinoma.

Authors:  Hui Wang; Zhengdong Zhang; Zhe Yan; Shihong Ma
Journal:  J Clin Lab Anal       Date:  2020-09-22       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.